Metaprotereol Sulfate Inhalation Solution, 5%
Company: Morton Grove PharmaceuticalsApproval Status: Approved March 1997
Treatment for: bronchial asthma and reversible bronchospasm
Areas: Respiratory
General Information
Metaprotereol Sulfate Inhalation Solution, 5% has been approved for the treatment of bronchial asthma and reversible bronchospasm. The product is also indicated for the treatment of acute asthmatic attacks in children over the age of six. Metaprotereol Sulfate Inhalation Solution, 5% was found to be therapeutically bioequivalent to the listed drug, Alupentr Inhalation Solution, 5% marketed by Boehringer Ingelheim Pharmaceuticals, Inc.
Metaprotereol Sulfate Inhalation Solution, 5% Drug Information
The Metaprotereol Sulfate Inhalation Solution, 5% drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
